FIS increases the cleavage of caspase-8 [49,52] and caspase-3 and the expression of cytochrome C. Surprisingly, treatment with FIS causes a higher level of cytochrome C release in chemotherapy-resistant cells than in nonresistant tumor cells [52]. Here, CASP3 is linked to neoplasm.